NCT05210335View on ClinicalTrials.gov

RISK ANALYSIS AND MANAGEMENT FOR MEDICATION OPTIMIZATION IN THE PREOPERATIVE AND POSTOPERATIVE PERIOD OF CARDIAC SURGICAL PATIENTS

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions
Drug Related ProblemsClinical PharmacyCardiac SurgeryRisk Assesment
Interventions
OTHER

Clinical pharmacist's recommendation to physicians about drug related problems

Clinical pharmacist's recommendation to physicians about drug related problems

Trial Locations (1)

06100

Hacettepe University Faculty of Pharmacy Department of Clinical Pharmacy, Ankara

All Listed Sponsors
lead

Hacettepe University

OTHER

NCT05210335 - RISK ANALYSIS AND MANAGEMENT FOR MEDICATION OPTIMIZATION IN THE PREOPERATIVE AND POSTOPERATIVE PERIOD OF CARDIAC SURGICAL PATIENTS | Biotech Hunter | Biotech Hunter